Become a Member
Dark Mode
Become a Member
Naukri Crisis
Uncovering Hate
Maharashtra Election
Manipur Conflict
Climate Change
Members Only
WebQoof
My Report
Brand Studio
FIT
Gender
Opinion
Videos
Entertainment
Sports
World
Explainers
More
Podcasts
Politics
The Quint Lab
Graphic Novels
Law
Education
Members' Opinion
South Asians
NEON
Dark Mode
Become a Member
Home
Naukri Crisis
Uncovering Hate
Maharashtra Election
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
Antiviral Pill
Anti COVID-19 Drug Without Side Effects Being Developed in India: CDRI
Members Only
Pfizer’s Anti-Viral Pill Shows Results Within 3 Days of Treatment: Report
ADVERTISEMENT
REMOVE AD
Molnupiravir COVID-19 Treatment Has 'Major Safety Concerns': ICMR Chief
EMA Approves Pfizer COVID-19 Pill for Emergency Use: Report
Members Only
Merck’s COVID Pill Shows Less Efficacy in Updated Data: What's Changed?
Members Only
After Pfizer, FDA Authorises Merck’s At-Home Antiviral COVID-19 Pill
Pfizer to Licence Its COVID-19 Pill to Low Income Countries: Report
Members Only
UK Approves First Antiviral Covid Pill: All You Need To Know
Members Only
Members Only
Anti COVID-19 Drug Without Side Effects Being Developed in India: CDRI
Pfizer’s Anti-Viral Pill Shows Results Within 3 Days of Treatment: Report
Molnupiravir COVID-19 Treatment Has 'Major Safety Concerns': ICMR Chief
Members Only
After Pfizer, FDA Authorises Merck’s At-Home Antiviral COVID-19 Pill
EMA Approves Pfizer COVID-19 Pill for Emergency Use: Report
Merck’s COVID Pill Shows Less Efficacy in Updated Data: What's Changed?
Members Only
Pfizer to Licence Its COVID-19 Pill to Low Income Countries: Report
UK Approves First Antiviral Covid Pill: All You Need To Know
Load More
